HIGHLIGHTS OF PRESCRIBING INFORMATION - Pfizer.pdf
HIGHLIGHTS OF PRESCRIBING INFORMATION ARICEPT.pdf
Aricept (donepezil) - Northwest Behavioral Medicine.pdf
Aricept (donepezil) Any suspected overdose should be treated as an emergency. The person should be taken to the emergency department for observation and treatment.www.psychatlanta.com/documents/aricept.pdf
This leaflet summarizes the most important information about ARICEPT. If you would like more inform ation talk with the patient’s doctor. You can ask yourwww.pfizer.com/sites/default/files/products/ppi_aricept.pdf
NDA 20-690/S-026 NDA 21-720/S-003 Page 3 ARICEPT® (Donepezil Hydrochloride Tablets) ARICEPT® ODT (Donepezil Hydrochloride) Orally Disintegrating Tabletswww.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory...
Gary Wieczorek Page 3 Eisai Medical Research Inc. NDA #20-690/MACMIS #18244 Aricept is contraindicated in patients with known hypersensitivity to the drug or to ...www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory...
aricept/exelon/reminyl/namenda prior authorization form—if this is urgent request, please call the upmc health plan pharmacy author: sarah lipski created date:www.upmchealthplan.com/pdf/PApdf/Aricept.pdf
12 New FDA Approved Labeling Aricept 23 mg tablets • Dosage and Administration – Mild to Moderate Alzheimer’s Disease – 5 mg or 10 mg administered once dailywww.eisai.com/pdf/eir/emat/material20100727e.pdf